CPHI Helps Internationalise Japanese and South East Asian Markets
UBM EMEA, leading organisers of CPHI South East Asia and CPHI Japan, celebrate the closing of two growing Asian events that took place 8–10 April and April 22–24 April respectively.
Collectively, these two shows represent the diverse pharma economies within Asia — the market in South East Asia is undergoing a period of fast development whereas Japan’s pharma market is one of the most mature in the world. CPHI Japan welcomed impressive numbers of over 16,000 visitors and 450+ exhibitors to the 3-day event. Significantly, over half of the exhibiting companies were from overseas — a surprising statistic considering Japan’s pharma market has long been considered domestically focused.
However, with the market’s recent awakening to the value of generics (to help supply the rising healthcare demand), international partnerships are fast becoming a driving force for Japan. The exhibition space for CPHI Japan 2015, which was the largest since 2002, highlights the increasing number of foreign companies that are looking to enter this pharma market, and we are forecasting a further rise over the coming years.
In contrast, the Indonesian pharma market has undergone remarkable growth and is now acting as the central hub for pharmaceuticals in the region. After a successful CPHI South East Asia event, feedback from the show floor suggests that Indonesia will not only see a significant growth in pharma manufacturing domestically, but will also become a key exporter to nearby economies.
Due to South East Asia’s complex landscape, we are likely to see an increased number of foreign-domestic partnerships. Overseas companies looking to capitalise on this dynamic market are likely to partner with local businesses that have the knowledge and distribution capabilities across all areas of the region. As a result, CPHI noted a significant influx of foreign companies now seeking new business and partnerships within the region; 261 companies, from 39 different countries exhibited at the 3-day event as well as 6211 visitors.
“CPHI facilitates opportunities for international collaboration and market entry by providing a platform for pharma executives to meet and build relationships all over the world. The South East Asia and Japan pharma markets are operating at different stages of development, yet both have the same goal of expanding their international outlook — Indonesia is developing at a fast pace and is ripe with opportunities for foreign companies and Japan is now welcoming overseas investors and generics companies.
Both CPHI South East Asia and CPHI Japan are the largest pharma events in their respective regions, and provide valuable insights into the region’s market rules, regulations and trends for potential overseas investors,” said Chris Kilbee, Group Director Pharma.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News Pharmapack 2024 - From the Floor
Paris once again welcomes Europe’s leading trade show in pharmaceutical packaging and drug delivery innovation. Join our content team as Pharmapack 2024 opens its doors to leading experts and innovators in pharmaceutical packaging and drug delive... -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News CPHI Barcelona 2023: Loading Potential – Artificial Intelligence for Pharma Manufacturing
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News Pharmaceutical industry supports COP28 health stance in joint statement
As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.&nb... -
News CPHI Podcast Series: Start-ups take centre stage at CPHI Barcelona
The first episode of the CPHI Podcast Series since we attended CPHI Barcelona in October covers the Start-up market at the event, with expert Matthew Wise joining Editor Lucy Chard to discuss the event.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance